menu
    • menu

    Company profile for NeuroNOS

    NEW Drugs in Dev: 2
    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Neuro-NOS is a pioneering biotech company specializing in next-generation neuroscience therapies, focusing on neurodegenerative diseases and neurological disorders. Leveraging cutting-edge research and innovative drug development, Neuro-NOS aims to deliver breakthrough treatments for conditions like Alzheimer’s, Parkinson’s, and ALS. With a strong foundation in molecular neuroscience and translational medicine, the company...
    Neuro-NOS is a pioneering biotech company specializing in next-generation neuroscience therapies, focusing on neurodegenerative diseases and neurological disorders. Leveraging cutting-edge research and innovative drug development, Neuro-NOS aims to deliver breakthrough treatments for conditions like Alzheimer’s, Parkinson’s, and ALS. With a strong foundation in molecular neuroscience and translational medicine, the company is committed to accelerating novel therapies from lab to clinic. Neuro-NOS collaborates with leading researchers and institutions to push the boundaries of brain health innovation.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NeuroNOSUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Boston, Massachusetts
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.neuro-nos.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/neuro-nos-n/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Asia Pharma Expo

    Asia Pharma Expo

    Not Confirmed

    envelop Contact Supplier

    Asia Pharma Expo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    XTL Update On Recent Developments
    XTL Update On Recent Developments

    29 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/29/3229091/0/en/XTL-Update-on-Recent-Developments.html

    GLOBENEWSWIRE
    29 Jan 2026
    Share Share
    XTL Bio Acquires 85% Beyond Air's Neuronos, Enters Autism Market
    XTL Bio Acquires 85% Beyond Air's Neuronos, Enters Autism Market

    13 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/13/3217669/0/en/XTL-Biopharmaceuticals-Acquires-85-of-Beyond-Air-s-Subsidiary-NeuroNOS-Entering-the-Massive-Autism-Market-with-Nobel-Prize-Winning-Scientific-Leadership.html

    GLOBENEWSWIRE
    13 Jan 2026
    Share Share
    FDA Grants NeuroNOS Orphan Drug Status for Glioblastoma in Adults
    FDA Grants NeuroNOS Orphan Drug Status for Glioblastoma in Adults

    08 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/08/3146057/0/en/NeuroNOS-Granted-FDA-Orphan-Drug-Designation-for-Glioblastoma-the-Most-Common-and-Deadliest-Primary-Malignant-Brain-Cancer-in-Adults.html

    GLOBENEWSWIRE
    08 Sep 2025
    Share Share
    NeuroNOS Receives FDA Orphan Designation for Phelan-McDermid
    NeuroNOS Receives FDA Orphan Designation for Phelan-McDermid

    21 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/21/3064971/0/en/NeuroNOS-Granted-FDA-Orphan-Drug-Designation-for-Phelan-McDermid-Syndrome-a-Neurodevelopmental-Disorder-Linked-to-Autism.html

    GLOBENEWSWIRE
    21 Apr 2025
    Share Share
    NeuroNOS Appoints Nobel Laureate Dan Shechtman to Advisory Board
    NeuroNOS Appoints Nobel Laureate Dan Shechtman to Advisory Board

    15 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/15/3062114/0/en/NeuroNOS-Appoints-Nobel-Prize-Laureate-Professor-Dan-Shechtman-to-Scientific-Advisory-Board.html

    GLOBENEWSWIRE
    15 Apr 2025
    Share Share
    NeuroNOS CSO Publishes Research on Alzheimer's Mechanism
    NeuroNOS CSO Publishes Research on Alzheimer's Mechanism

    01 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/01/3053310/0/en/NeuroNOS-Announces-Groundbreaking-Research-Publication-by-its-CSO-Demonstrating-Mechanism-of-Action-in-Alzheimer-s-Disease-and-Reinforcing-Platform-s-Strength-Across-Neurological-D.html

    GLOBENEWSWIRE
    01 Apr 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search